These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 24023628)

  • 61. Structural and functional analysis of the CspB protease required for Clostridium spore germination.
    Adams CM; Eckenroth BE; Putnam EE; Doublié S; Shen A
    PLoS Pathog; 2013 Feb; 9(2):e1003165. PubMed ID: 23408892
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An Osmotic Laxative Renders Mice Susceptible to Prolonged Clostridioides difficile Colonization and Hinders Clearance.
    Tomkovich S; Taylor A; King J; Colovas J; Bishop L; McBride K; Royzenblat S; Lesniak NA; Bergin IL; Schloss PD
    mSphere; 2021 Oct; 6(5):e0062921. PubMed ID: 34585964
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Outcome of relapsing Clostridium difficile infections do not correlate with virulence-, spore- and vegetative cell-associated phenotypes.
    Plaza-Garrido Á; Miranda-Cárdenas C; Castro-Córdova P; Olguín-Araneda V; Cofré-Araneda G; Hernández-Rocha C; Carman R; Ibáñez P; Fawley WN; Wilcox MH; Gil F; Calderón IL; Fuentes JA; Guzmán-Durán AM; Alvarez-Lobos M; Paredes-Sabja D
    Anaerobe; 2015 Dec; 36():30-8. PubMed ID: 26403333
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Redistribution of the Novel Clostridioides difficile Spore Adherence Receptor E-Cadherin by TcdA and TcdB Increases Spore Binding to Adherens Junctions.
    Castro-Córdova P; Otto-Medina M; Montes-Bravo N; Brito-Silva C; Lacy DB; Paredes-Sabja D
    Infect Immun; 2023 Jan; 91(1):e0047622. PubMed ID: 36448839
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A combination of the probiotic and prebiotic product can prevent the germination of Clostridium difficile spores and infection.
    Rätsep M; Kõljalg S; Sepp E; Smidt I; Truusalu K; Songisepp E; Stsepetova J; Naaber P; Mikelsaar RH; Mikelsaar M
    Anaerobe; 2017 Oct; 47():94-103. PubMed ID: 28465256
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pleiotropic roles of Clostridium difficile sin locus.
    Girinathan BP; Ou J; Dupuy B; Govind R
    PLoS Pathog; 2018 Mar; 14(3):e1006940. PubMed ID: 29529083
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Germination of spores of Clostridium difficile strains, including isolates from a hospital outbreak of Clostridium difficile-associated disease (CDAD).
    Paredes-Sabja D; Bond C; Carman RJ; Setlow P; Sarker MR
    Microbiology (Reading); 2008 Aug; 154(Pt 8):2241-2250. PubMed ID: 18667557
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fidaxomicin preserves the intestinal microbiome during and after treatment of Clostridium difficile infection (CDI) and reduces both toxin reexpression and recurrence of CDI.
    Louie TJ; Cannon K; Byrne B; Emery J; Ward L; Eyben M; Krulicki W
    Clin Infect Dis; 2012 Aug; 55 Suppl 2(Suppl 2):S132-42. PubMed ID: 22752862
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Domestic canines do not display evidence of gut microbial dysbiosis in the presence of Clostridioides (Clostridium) difficile, despite cellular susceptibility to its toxins.
    Stone NE; Nunnally AE; Jimenez V; Cope EK; Sahl JW; Sheridan K; Hornstra HM; Vinocur J; Settles EW; Headley KC; Williamson CHD; Rideout JR; Bolyen E; Caporaso JG; Terriquez J; Monroy FP; Busch JD; Keim P; Wagner DM
    Anaerobe; 2019 Aug; 58():53-72. PubMed ID: 30946985
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Triggering germination represents a novel strategy to enhance killing of Clostridium difficile spores.
    Nerandzic MM; Donskey CJ
    PLoS One; 2010 Aug; 5(8):e12285. PubMed ID: 20808871
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Spore Coat Protein CotE Facilitates Host Colonization by Clostridium difficile.
    Hong HA; Ferreira WT; Hosseini S; Anwar S; Hitri K; Wilkinson AJ; Vahjen W; Zentek J; Soloviev M; Cutting SM
    J Infect Dis; 2017 Dec; 216(11):1452-1459. PubMed ID: 28968845
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Bile salt inhibition of host cell damage by Clostridium difficile toxins.
    Darkoh C; Brown EL; Kaplan HB; DuPont HL
    PLoS One; 2013; 8(11):e79631. PubMed ID: 24244530
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clostridium difficile and the microbiota.
    Seekatz AM; Young VB
    J Clin Invest; 2014 Oct; 124(10):4182-9. PubMed ID: 25036699
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A 3D intestinal tissue model supports Clostridioides difficile germination, colonization, toxin production and epithelial damage.
    Shaban L; Chen Y; Fasciano AC; Lin Y; Kaplan DL; Kumamoto CA; Mecsas J
    Anaerobe; 2018 Apr; 50():85-92. PubMed ID: 29462695
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Conserved oligopeptide permeases modulate sporulation initiation in Clostridium difficile.
    Edwards AN; Nawrocki KL; McBride SM
    Infect Immun; 2014 Oct; 82(10):4276-91. PubMed ID: 25069979
    [TBL] [Abstract][Full Text] [Related]  

  • 76. 2'-Fucosyllactose inhibits proliferation of
    Wiese M; Schuren FHJ; Smits WK; Kuijper EJ; Ouwens A; Heerikhuisen M; Vigsnaes L; van den Broek TJ; de Boer P; Montijn RC; van der Vossen JMBM
    Front Cell Infect Microbiol; 2022; 12():991150. PubMed ID: 36389156
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Engineering probiotics to inhibit Clostridioides difficile infection by dynamic regulation of intestinal metabolism.
    Koh E; Hwang IY; Lee HL; De Sotto R; Lee JWJ; Lee YS; March JC; Chang MW
    Nat Commun; 2022 Jul; 13(1):3834. PubMed ID: 35787625
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical, epidemiological and microbiological characteristics of relapse and re-infection in Clostridium difficile infection.
    Gómez S; Chaves F; Orellana MA
    Anaerobe; 2017 Dec; 48():147-151. PubMed ID: 28830842
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Design, Synthesis, and Characterizations of Spore Germination Inhibitors Effective against an Epidemic Strain of Clostridium difficile.
    Sharma SK; Yip C; Esposito EX; Sharma PV; Simon MP; Abel-Santos E; Firestine SM
    J Med Chem; 2018 Aug; 61(15):6759-6778. PubMed ID: 30004695
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infection.
    Crowther GS; Baines SD; Todhunter SL; Freeman J; Chilton CH; Wilcox MH
    J Antimicrob Chemother; 2013 Jan; 68(1):168-76. PubMed ID: 22966180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.